Section I. Introduction to diagnosis and laboratory techniques 1. Approaches to Classification of Lymphoma and Leukemia Dan Jones, MD, PhD 2. Immunohistochemical Profiling of Lymphoma Matthew Anderson, MD, PhD, Yasodha Natkunam, MD, PhD 3. Flow Cytometry in the Evaluation of Hematologic Malignancies Jeffrey L Jorgensen, MD, PhD 4. Molecular Diagnostics and Cytogenetic Testing Su Chen, MD, PhD, Zhuang Zuo, MD, PhD, Dan Jones, MD Section II. Neoplasms of the Bone Marrow 5. The Bone Marrow in Normal and Diseased States Dan Jones, MD, PhD, Roberto N Miranda, MD 6. Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms Sa A Wang, MD 7. Acute Myeloid Leukemia Carlos E Bueso-Ramos, MD, PhD 8. Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes Farhad Ravandi, MD 9. Myeloproliferative Neoplasms C. Cameron Yin, MD, PhD, Dan Jones, MD, PhD 10. Chronic Myelogenous Leukemia Robert P Hasserjian, MD 11. Treatment of Myeloproliferative Neoplasms Starla Sweany, PharmD, BCOP, Elias Jabbour, MD Section III. Tumors of the Lymph Node and Extranodal Tissues 12. Lymph Node Biology and Lymphadenitis Roberto N Miranda, MD 13. Lymphoblastic Leukemia and Lymphoma Andrea M Sheehan, MD 14. Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Ellen Schlette, MD 15. Marginal Zone Lymphomas Rachel L Sargent, MD 16. Follicular Lymphoma and Mantle Cell Lymphoma Dan Jones, MD 17. Aggressive B-Cell Lymphomas: Large B-Cell Lymphoma and Burkitt Lymphoma Henry Y Dong, MD, PhD 18. Therapy of B-Cell Lymphoproliferative Disorders Nathan Fowler, MD, Sandra Horowitz, PharmD, Peter McLaughlin, MD 19. Plasma Cell Myeloma and Other Plasma Cell Dyscrasias Marwan A Yared, MD 20. Hodgkin Lymphoma Robert Lin, MD, Dan Jones, MD, PhD, Sherif Ibrahim, MD, PhD 21. Treatment of Hodgkin Lymphoma Luis E Fayad, MD, Samer A Srour, MB, ChB 22. Classification of T-Cell and NK-Cell Malignances Dan Jones, MD, PhD 23. Treatment of Non-Cutaneous T-Cell and NK-Cell Malignancies Marco Herling, MD 24. Cutaneous T-Cell Lymphoma Pranil Chandra, DO, Mauricio P Oyarzo, MD, Dan Jones, MD, PhD 25. Treatment of Cutaneous T-Cell Lymphomas Katherine M Cox, MD, Madeleine Duvic, MD 26. Histiocytic and Dendritic Cell Neoplasms Kedar V Inamdar, MD, PhD, Dan Jones, MD, PhD 27. Extranodal Lymphomas and Tumors of the Thymus Brian D Stewart, MD, John T Manning, MD, Dan Jones, MD Section IV. Stem Cell Transplantation 28. Clinical Aspects of Hematopoietic Stem Cell Transplantation Elizabeth J Shpall, MD, Marcos de Lima, MD 29. Post-Transplant Molecular Monitoring Dan Jones, MD, PhD 30. Post-Transplant Immune Function and the Development of Lymphoma Dequin Ma, MD, PhD and Dan Jones, MD, PhD Section V. Experimental Hematopathology 31. Hematopoiesis and Stem Cell Biology Claudiu Cotta, MD, PhD 32. Role of Host Genetics in Lymphoma Ahmet Dogan, MD, PhD 33. Developing Prognostic Models for Diffuse Large B-Cell Lymphoma Izidore S Lossos, MD 34. Growth Signaling and Survival Pathways in Aggressive B-Cell Lymphoma Lan V Pham, PhD, Richard J Ford, MD, PhD 35. Proteomic Profiling and Target Identification in Lymphoma Megan S Lim, MD, PhD 36. Mouse Models of Lymphoma and Lymphoid Leukemia M James You, MD, PhD 37. Mouse Models of Myeloid Leukemia Robert B Lorsbach, MD, PhD 38. Designing Targeted Therapies for Lymphomas and Leukemias <
